跳至主要内容
临床试验/NCT03327272
NCT03327272撤回3 期

Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion

Rush University Medical Center1 个研究点 分布在 1 个国家开始时间: 2018年5月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
试验地点
1
主要终点
Postoperative Pain

研究概览

简要总结

Neural injury is a well-known complication following extreme lateral lumbar interbody fusion (XLIF). It has been found that up to 9.4% of patients will have either temporary or persistent neurologic deficit. This occurs with traversal of the psoas muscle or direct injury to lumbosacral plexus or sympathetic ganglion. While often temporary, it can cause hip flexor weakness, thigh numbness, or pain.

Several studies have demonstrated reduced patient reported pain scores following steroid administration, particularly in the early postoperative period. However, few studies have investigated the efficacy of intraoperative local injection of corticosteroid in reducing the incidence and duration of postoperative pain or neurologic injury for XLIF patients.

详细描述

The purpose of this study is to determine if the incidence and duration of postoperative pain is reduced in the subjects receiving a local injection of methylprednisolone when compared to placebo following XLIF.

The investigators hypothesize that subjects undergoing XLIF who receive local methylprednisolone will have:

  1. Reduced incidence and duration of postoperative pain and neurologic injury
  2. Shorter hospital stay
  3. Better short- and long-term outcomes

The study also aims to answer the following questions:

  1. Do subjects who receive local corticosteroids have a reduced incidence and duration of postoperative pain and neurologic deficit compared to those who receive placebo?
  2. Do subjects who receive local corticosteroids have a reduced hospital stay compared to those who received placebo?
  3. Is local corticosteroid therapy associated with improved short and long-term outcomes?

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients undergoing a 1- to 2-level XLIF
  • Diagnosis: myelopathy, radiculopathy, myeloradiculopathy, stenosis, herniated nucleus pulposus, degenerative disc disease, spondylosis, osteophytic complexes, and foraminal stenosis
  • Patients able to provide informed consent

排除标准

  • Allergies or other contraindications to medicines in the protocol including:
  • Existing history of gastrointestinal bleeding
  • Lumbar spine trauma
  • Unable to speak, read, or understand English

研究组 & 干预措施

Local injection of methylprednisolone

Active Comparator

Drug: methylprednisolone Injection of 80mg methylprednisolone injectable suspension at surgical site prior to incision closure

干预措施: Methylprednisolone (Drug)

Local injection of saline

Placebo Comparator

Administration of saline at surgical site prior to incision closure.

干预措施: Saline (Drug)

结局指标

主要结局

Postoperative Pain

时间窗: 2 year postoperative

Change in Visual Analogue Scale (VAS) Back and Leg pain score from preoperative value will be assessed. VAS back and leg pain scores assess pain in each region on a scale from 0-10 with 0 being no pain and 10 being worst pain imaginable.

次要结局

  • Disability(2 year postoperative)
  • Narcotic Consumption(2 year postoperative)
  • Length of Stay(1 week postoperative)
  • General health status(2 year postoperative)
  • Physical Functioning(2 year postoperative)
  • Post-operative adverse events(1 week postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kern Singh

Professor, Department of Orthopaedic Surgery

Rush University Medical Center

研究点 (1)

Loading locations...

相似试验